A nationwide survey concerning practices in pessary use for pelvic organ prolapse in The Netherlands: identifying needs for further research by Velzel, J. (Joost) et al.
ORIGINAL ARTICLE
A nationwide survey concerning practices in pessary
use for pelvic organ prolapse in The Netherlands: identifying
needs for further research
Joost Velzel1,2 & Jan Paul Roovers1 & C H Van der Vaart3 & Bart Broekman4 &
Astrid Vollebregt2 & Robert Hakvoort2
Received: 16 December 2014 /Accepted: 16 March 2015 /Published online: 11 June 2015
# The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract
Introduction and hypothesis To identify practice variation in
management of patients with a vaginal pessary for pelvic or-
gan prolapse (POP).
Methods A nationwide survey was sent to all Dutch gynecol-
ogists with a special interest in urogynecology.
Results The response rate was 59%.Of the respondents, 13%
had a written protocol for pessary treatment in their depart-
ment. Pessary treatment was proposed by 69% of respondents
as a treatment option. Counseling about side effects varied.
All respondents provided information concerning the possi-
bility of serious vaginal discharge. Concerning this side effect,
15 % of the respondents stated that it occurs in 5 – 20 % of
patients, 27% that it occurs in 20 – 40% of patients, and 57%
that it occurs in more than 40 % of patients. Another item
concerned counseling for the likelihood of vaginal blood loss.
All respondents provided information concerning the possi-
bility of vaginal blood loss. Concerning this side effect, 53 %
of the respondents stated that it occurs in 5 – 20 % of patients,
33 % that it occurs in 20 – 40 %, and 14 % that it occurs in
more than 40 % of patients. Follow-up after initial placement
was done by 69% of the respondents at 2 – 6 weeks, by 2% at
8 weeks, and by 29% at 12weeks or more. Most (98%) of the
respondents extended the interval between visits when the
patient had no complaints, and 96 % of the respondents re-
ported that they routinely instruct patients about self-
management.
Conclusions Pessaries are suggested as a treatment option by
a majority of gynecologists, but practice varies widely. We
consider that the variation in practice is due to a lack of
available protocols and lack of evidence.
Keywords Prolapse . Pessary . Survey . Prolapse
management
Introduction
Pelvic organ prolapse (POP) is a common condition in adult
women [1]. For the relief of symptoms related to POP conser-
vative treatment options include life-style advice, pelvic phys-
iotherapy and pessary treatment [2–4]. The aim of pessary
treatment is to restore the anatomy of the visceral organs of
the pelvic cavity by inserting a device into the vagina. The
reported subjective cure rates vary between 60% and 80% [5,
6]. Many patients prefer this treatment over surgery, as it is
unlikely to cause serious morbidity and normal activities can
be continued [7–10]. Successful pessary fitting and long-term
success have been documented in up to 75 % of women with
symptomatic POP [11–14]. The reason for the high proportion
(80 – 85 %) of gynecologists placing pessaries may be the
ease with which they can be inserted and removed, their effi-
cacy and the low complication rate [15, 16].
Although large groups of women receive these devices, a
national guideline regarding POP was not available in
The Netherlands at the time of our survey. The proportion of
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patients made aware of this treatment option, which patients
are most eligible for this treatment, and how long follow-up
intervals should be were unknown. Ignorance concerning the-
se issues may result in practice variation and suboptimal treat-
ment of patients. Therefore, the aim of the present survey was
to identify current practice and variation in practice
concerning treatment with vaginal pessaries for POP.
Materials and methods
An invitation to participate was sent to all 151 members of the
Dutch working party for urogynecology of the Dutch College
for Obstetrics and Gynecology. This membership represents
15.4% of the 981 Dutch gynecologists.We expected all mem-
bers of the Dutch working party for urogynecology to be fa-
miliar with the indications for and performance of pessary
treatment. Participants were asked to answer the survey using
an online system (SurveyMonkey®). A reminder was sent to
those who had not responded 4 weeks after the first request.
Nonresponders were sent a third request 4 weeks after the
second request.
The questionnaire was developed specifically for the sur-
vey based on previous questionnaires [15, 16] and by a panel
of four experts in urogynecology. The questionnaire included
both multiple choice and open questions addressing the fol-
lowing topics: characteristics of gynecologists and hospitals,
selection of patients, follow-up management and counseling
patients about side effects, effectiveness and the option of self-
management. We asked the respondents to answer as if con-
sidering a patient without a previous pessary fitting trial. The
full questionnaire can be found in Table 5 in the Appendix.
Ethics review board approval was not applied for.
Data from the completed questionnaires were used to cal-
culate frequencies and percentages of respondents answering
per question per topic. Descriptive data analysis was per-
formed using SPSS 19.0 (SPSS Statistics UK, SPSS Inc.,
Chicago, IL).
Results
After three requests, a total of 91 of 151 gynecologists (59 %)
in 63 of 80 hospitals (79 %) had responded. In 98 % of the
responding hospitals a gynecologist with a special interest in
urogynecology was employed. A written protocol for indica-
tion, insertion and follow-up of pessary treatment was avail-
able in 13 % (Table 1).
Pessary placement for the treatment of POP was proposed
by 69 % of respondents always, by 17 % sometimes, and by
14 % never. Prolapse of the anterior compartment and apical
compartment were considered the most suitable indications
for pessary treatment (99 % and 96 % of the respondents,
respectively). Concerning the decision to start initial treatment
with a pessary, 62 % of the respondents stated that they were
not influenced by the stage of prolapse, and 36 % stated that
patient age was a decisive factor, with younger patients being
less likely to receive a pessary (Table 2).
Table 3 shows the protocols and practices of gynecologists
concerning follow-up after initial placement. The interval be-
tween initial placement and first follow-up varied from
2weeks to 16weeks. The first follow-up visits were at 2weeks
(17 % of respondents), 3 weeks (15 %), 4 weeks (14 %),
Table 1 Characteristics of the hospitals of responding gynecologists
No. (%) of
respondents
Type of hospital General hospital 26 (29)
Teaching hospital 55 (60)
Academic hospital 9 (10)
Private practice 1 (1)
New patients with vaginal
prolapse annually
0 – 400 24 (26)
401 – 800 46 (51)
>800 21 (23)
Vaginal prolapse surgery
procedures annually
0 – 100 14 (15)
101 – 200 52 (57)
>200 25 (28)
Gynecologist with special
interest urogynecology
Yes 89 (98)
No 2 (2)
Existence of written protocol
for pessary use
Yes 12 (13)
No (but consensus
among caregivers)
54 (59)
No 25 (27)
Table 2 Selection of patients
No. (%) of
respondents
Standard information
about the option of
a pessary
Yes 63 (69)
Occasionally 15 (17)
No 13 (14)
Type of prolapse thought
to be most suitable for
pessarya
Prolapse anterior compartment 88 (99)
Prolapse middle compartment 85 (96)
Prolapse posterior
compartment
9 (11)
Stress incontinence 11 (12)
Urge incontinence 8 (9)
Constipation 0 (0)
Obstructed defecation 26 (29)
Influence of prolapse
stage on decision
Yes 35 (38)
No 56 (62)
Influence of patient age
on decision
Yes 33 (36)
No 58 (64)
aMore answers possible
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6 weeks (23 %), 8 weeks (2 %), 12 weeks (23 %), and
16 weeks (6 %).
Regarding the first follow up visit, 78 respondents (86 %)
stated that it was carried out by a gynecologist, 2 % delegated
this care to either the general practitioner (GP) or a nurse
practitioner, and 12 % stated that the patient could choose
between the above professionals. If there were no patient com-
plaints, 99 % of respondents increased the interval between
visits. Estrogens were prescribed routinely by 13% of respon-
dents, only when vaginal atrophy was present by 73 %, and
when indications other than atrophy, for example irritation,
were present by 9 %; 5 % of respondents never prescribed
estrogens.
Counseling about side effects varied. All respondents pro-
vided information concerning the possibility of serious vagi-
nal discharge. Concerning this side effect, 15 % of the respon-
dents stated that it occurs in 5 – 20 % of patients, 27 % that it
occurs in 20 – 40 % of patients, and 57 % that it occurs in
more than 40 % of patients. Another item concerned counsel-
ing for the likelihood of vaginal blood loss. All respondents
provided information concerning the possibility of vaginal
blood loss. Concerning this side effect, 53 % of the respon-
dents stated that it occurs in 5 – 20 % of patients, 33 % that it
occurs in 20 – 40%, and 14% that it occurs in more than 40%
of patients. Concerning the success rates of pessary treatment,
5 % of respondents informed patients that pessary treatment is
successful in only 5 – 20 % of patients, 46 % that it is suc-
cessful in 20 – 50 % of patients, and 48 % that it is successful
in more than 50 % of patients. The likelihood of eventually
receiving surgical treatment following failure of pessary treat-
ment was stated to be 0 – 25 % by 24 % of respondents,
25 – 50 % by 56 % and more than 50 % by 20 %. Of the
respondents who proposed pessaries as a treatment option,
96 % informed the patient about the possibility of self-
management (Table 4).
Discussion
A nationwide survey was performed to quantify the variation
among gynecologists in the practice of pessary treatment in
women with symptomatic POP. A low percentage (only 13%)
of respondents stated that they had a written protocol available
in their department. A relatively high percentage (69 %) of
respondents routinely suggested pessary treatment for POP. A
considerable variation was found in counseling about vaginal
discharge and vaginal blood loss as possible side effects. Fur-
thermore, the intervals between placement and the first
follow-up visit varied greatly. A majority of the respondents
reported that they routinely instruct the patient about self-
management.
Before discussing these results in more detail, we address
some limitations of this study. A criticism might be that the
59 % response rate did not reflect overall clinical practice.
However, the respondents represented 79 % of Dutch depart-
ments. Failure of a proportion of potential participants to re-
spond means that trends that could have been recognized were
missed. There could have been a reporting bias favoring youn-
ger potential participants due to the online survey tool used.
However, it is not clear how this could have affected the re-
sults. As previous surveys on this topic had response rates of
21 % [15] and 55 % [16] we consider that the response rate
can be regarded as high. Another possible limitation was the
way in which questions were formulated. To be able to obtain
answers that could be more easily analyzed multiple choice
questions were mainly used, which may not always have
reflected actual practice. Unfortunately, this is inherent in the
survey format.
Also GPs contribute to this type of care, estimated in
The Netherlands to be around 20 % of the total amount of
care, but this group was not interviewed. There is no expertise
in pessary treatment for POP among other groups in
The Netherlands, for example nurse practitioners. It would
have been interesting to perform a similar survey among
GPs to gain an insight into their use of pessaries in the man-
agement of POP. Because of the relatively small contribution
of GPs to this care we decided not to include GPs in the study.
Table 3 Follow up
No. (%) of
respondents
First follow-up visit
(weeks)
2 15 (17)
3 14 (15)
4 13 (14)
6 21 (23)
8 2 (2)
12 21 (23)
16 5 (6)
Professional responsible
for first follow-up visit
Same caregiver 30 (33)
Same caregiver, later general
practitioner
48 (53)
Same caregiver or general
practitioner
1 (1)
Specialist nurse 1 (1)
Patient wishes 11 (12)
Timing of follow-up visits
after initial placementa
Same interval continued 15 (16)
Shorter intervals if complaints 27 (30)
Longer intervals if no
complaints
90 (99)
Prescription of estrogens
(oral and vaginal)
Yes 12 (13)
When indicated (vaginal
atrophy)
66 (73)
When indicated (other than
atrophy)
8 (9)
No 5 (5)
aMore answers possible
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Furthermore, we recognize that this survey only dealt with
daily practice in The Netherlands. Similar surveys in more
countries could generate information of more clinical value.
The study clearly demonstrated that a considerable propor-
tion (69 %) of gynecologists provide informs about the possi-
bility of pessary treatment. The available literature clearly in-
dicates that a high proportion of patients become long-term
users with a high patient satisfaction [10, 13, 17]. This may be
a result of the high percentage of patients who receive infor-
mation about this treatment. In general, respondents consid-
ered pessary treatment for prolapse of the anterior and apical
compartments as more successful than pessary treatment for
prolapse of the posterior compartment. In literature, there is no
definitive evidence that pessary use for posterior compartment
prolapse is not as successful as pessary treatment for anterior
wall prolapse [12, 18, 19]. The two largest studies have dem-
onstrated [12, 18] no difference in the success of pessary treat-
ment in relation to the type and severity of prolapse, and
conclude that patients should not be selected for pessary treat-
ment on the basis of the type of prolapse.
Information given to patients about adverse effects of
pessary treatment varied to a great extent and the
information that was given about the occurrence of side
effects was often not in line with existing evidence. Vag-
inal discharge has been reported to occur in 25 % of
patients [20] and vaginal blood loss in 6 – 46 % of pa-
tients [20–22] at 1 year after treatment. A large proportion
(57 %) of respondents considered (and possibly discussed
with patients) that serious vaginal discharge occurs more
frequently than it actually does. These discrepancies be-
tween perceived and actual complication rates may nega-
tively affect the willingness of the gynecologist to pro-
pose and of the patient to undergo pessary treatment.
Large differences in follow-up intervals were reported by
the respondents. Shorter intervals could be associated with
unnecessary higher costs per patient. However, there is no
clarity in the literature as to the ideal or minimal follow-up
intervals after initial placement. Neither is there any evidence
concerning the proportion of patients who are able to learn to
clean and replace the pessary themselves. A majority of the
respondents reported that they routinely instruct patients about
self-management, including how to change and clean the pes-
sary at home. However, from this survey we cannot determine
the success of this advice and training.
Table 4 Patient information and
self-management No. (%) of
respondents
Likelihood of side effects of pessary use Vaginal discharge 5 – 20 % 14 (15)
20 – 40 % 25 (27)
>40 % 52 (57)
Vaginal blood loss 5 – 20 % 48 (53)
20 – 40 % 30 (33)
>40 % 13 (14)
Likelihood of surgical treatment for POP
after pessary treatment
0 – 25 % 22 (24)
25 – 50 % 51 (56)
50 – 75 % 17 (19)
75 – 100 % 1 (1)
Likelihood of pessary extrusion 5 – 15 % 36 (40)
15 – 30 % 45 (49)
30 – 50 % 8 (9)
>50 % 2 (2)
Likelihood of that pessary treatment
will be effective/satisfactory
5 – 20 % 5 (5)
20 – 50 % 42 (46)
>50 % 44 (48)
Gynecologist giving advice
about self-management
Always 46 (51)
Regularly 41 (45)
No 4 (4)
Gynecologists giving instructions
about self-management
Yes, always 48 (53)
Regularly 39 (43)
No 4 (4)
Patients successful in self-management
returning to outpatient clinic
Yes 36 (40)
No 55 (60)
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Conclusions
This survey clearly showed that there is large variation in the
use of pessaries in the management of POP. This includes the
information patients are provided with. Other variations con-
cern follow-up after placement. A prospective study regarding
effectiveness and consequences of the use of pessaries in the
management of POP, and patient satisfaction with this ap-
proach, is needed.
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Appendix 1
Table 5 Full survey questionnaire
Topic 1: Characteristics of gynecologists and hospitals
A] In what type of department
do you work?
General hospital
Teaching hospital
Academic hospital
Private practice
B] How many new patients with
vaginal prolapse are seen in
your clinic annually?
0 – 200
201 – 400
401 – 600
601 – 800
>800
C] How many vaginal prolapse
surgery cases are there in
your clinic annually?
0 – 100
101 – 150
151 – 200
201 – 300
>300
D] How many new patients with
incontinence are seen in your
clinic annually?
0 – 25
26 – 50
51 – 75
76 – 100
>100
E] Is there a gynecologist with
a special interest in
urogynecology employed
in your clinic?
Yes
No
F] Is there a written protocol
for pessary use in your
clinic?
Yes
No, but consensus
between caregivers
No
Topic 2: Selection of patients
A] Do you propose pessary
placement as your standard
initial treatment?
Yes
Not in some cases
No
Table 5 (continued)
B] What type of prolapse or
complaint is most suitable
for pessary treatment
(multiple-choice question)?
Prolapse anterior
compartment
Prolapse middle
compartment
Prolapse posterior
compartment
Stress incontinence
Urge incontinence
Constipation
Obstructed defecation
C] Does stage of prolapse
influence pessary treatment?
Yes
No
D] Does patient age influence
pessary treatment?
Yes
No
Topic 3: Follow-up management
A] What is the interval to the
first follow-up after initial
placement in weeks?
2weeks
3weeks
4weeks
6weeks
8weeks
12weeks
16weeks
B] Which professional is
responsible for the first
follow-up visit after
initial placement
Same caregiver
Same caregiver, later on
general practitioner
Same caregiver or general
practitioner
A specialist nurse
Patient wishes
C] Do the intervals between
follow-up visits change
after initial placement
(multiple-choice question)?
Same interval continued
Shorter intervals if
complaints
Longer intervals if no
complaints
D] Do you prescribe estrogens
(oral or vaginal use)?
Yes
When indicated
(vaginal atrophy)
When indicated
(other than atrophy)
No
Topic 4: Information gynecologists provides to patients including
the option of self-management
A] How often does vaginal
discharge occur due to
pessary treatment for
prolapse?
5–20%
20–40%
40–60%
60–75%
>75%
B] How often does vaginal blood
loss occur due to pessary
treatment for prolapse?
5–20%
20–40%
40–60%
60–75%
>75%
C] What is the average chance
on getting surgical treatment
for prolapse after pessary
treatment?
0–25%
25–50%
50–75%
75–100%
D] How often does pessary
extrusion occur?
5–15%
15–30%
30–50%
>50%
E] What Information do you
give about the chance that
pessary treatment will be
effective/satisfactory?
5–20%
20–50%
>50%
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Table 5 (continued)
F] Do you give advice on
self-management?
Always
Regularly
No
G] Do you give instructions
on self-management?
Always
Regularly
No
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